GlassScriptPhysician profile
Trey A Gunter
NPI 1700264728
$10,141.21
in general payments reported to CMS, 2019-2025
40 companies · $1,083 in 2025
The $1,083 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,791 · 2020: $2,017 · 2021: $1,461 · 2022: $1,060 · 2023: $1,380 · 2024: $1,349 · 2025: $1,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,811.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,417.24 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,169.16 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $976.41 | 2019-2025 | Jardiance, Ofev |
| Amgen INC. | $622.83 | 2019-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $614.53 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amarin Pharma, INC. | $574.21 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $483.06 | 2019-2025 | |
| Pfizer INC. | $480.98 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $478.50 | 2019-2025 | |
| Glaxosmithkline, LLC. | $468.95 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Abbvie INC. | $361.90 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $292.78 | 2021-2024 | |
| Kowa Pharmaceuticals America, INC. | $254.24 | 2019-2024 | Livalo, Seglentis |
| Daiichi Sankyo INC. | $219.65 | 2019-2022 | |
| Abbott Laboratories | $214.47 | 2023-2025 | Freestyle Libre 2, Freestyle Libre 3 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trey Gunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.